How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Doug Mahoney Doug Mahoney is a writer covering home-improvement topics, ...
Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Somer G. Anderson is CPA, doctor of accounting, and an accounting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results